Compare Align Technology, Inc. (ALGN) vs Synchrony Financial (SYF) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs Synchrony Financial — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while Synchrony Financial trades at $72.44 (market cap $24.37B). The key difference: Synchrony Financial is the larger of the two by market cap, and Synchrony Financial pays a 1.66% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | SYF | |
|---|---|---|
Market Cap | $12.86B | $24.37B |
Sector | Health | Financials |
52-Week High | $207.19 | $88.47 |
52-Week Low | $124.88 | $63.78 |
Enterprise Value | $11.92B | — |
Dividend Yield | — | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Synchrony Financial (SYF) trades at $72.44, up 1.22% with strong fundamental metrics including a low P/E of 7.5 and robust ROE of 22.98%. The company has consistently beaten earnings expectations in recent quarters, with Q2 2026 results expected July 21. Technical indicators show bearish momentum despite neutral oscillators, with key support at $69 and resistance at $73. Recent corporate developments include executive leadership changes and expansion of CareCredit partnerships.
SYF presents a compelling value opportunity with attractive valuation multiples and consistent earnings performance. The stock offers 19% upside to consensus price target of $86, supported by strong analyst sentiment (62.5% buy ratings). Key risks include economic sensitivity to consumer credit and inflationary pressures. The upcoming Q2 earnings report will be crucial for confirming the company's growth trajectory amid current market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Synchrony Financial
Synchrony Financial is a premier consumer financial services company and the largest provider of private-label credit cards in the United States. Spun off from GE Capital in 2014, it operates through a unique B2B2C model, embedding its financing products within the ecosystems of major partners like Amazon, Lowe’s, and PayPal. Synchrony leverages deep data analytics and a diverse multi-platform strategy—spanning retail, health, and auto—to drive customer loyalty and provide specialized credit solutions at the point of sale.
Read more on SYF →
